Voyageur Pharmaceuticals Ltd.
TSXV: VM.V0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Toronto Stock Exchange Ventures
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Brent Willis
- Employees
- 49
- Headquarters
- Calgary, Canada
- IPO year
- 2013
- Market cap
- CA$17.9M
- Website
- https://voyageurpharmaceuticals.ca
Loading VM…
Loading profile data…Frequently asked questions about VM
What does Voyageur Pharmaceuticals Ltd. (VM.V) do?
Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barit...
Where does VM.V trade?
Voyageur Pharmaceuticals Ltd. (VM.V) trades on the Toronto Stock Exchange Ventures.
What sector is VM.V in?
Voyageur Pharmaceuticals Ltd. (VM.V) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Voyageur Pharmaceuticals Ltd.?
Brent Willis is the chief executive officer of Voyageur Pharmaceuticals Ltd. (VM.V).
Where is Voyageur Pharmaceuticals Ltd. headquartered?
Voyageur Pharmaceuticals Ltd. is headquartered in Canada.
Does VM.V pay a dividend?
Voyageur Pharmaceuticals Ltd. (VM.V) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VM.V go public?
Voyageur Pharmaceuticals Ltd. (VM.V) completed its initial public offering in 2013.